Caseware UK (AP4) 2023.0.135 2023.0.135 2024-05-312024-05-31true2023-06-01falseNo description of principal activity11trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 10785555 2023-06-01 2024-05-31 10785555 2022-06-01 2023-05-31 10785555 2024-05-31 10785555 2023-05-31 10785555 c:Director1 2023-06-01 2024-05-31 10785555 d:FurnitureFittings 2023-06-01 2024-05-31 10785555 d:FurnitureFittings 2024-05-31 10785555 d:FurnitureFittings 2023-05-31 10785555 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-06-01 2024-05-31 10785555 d:OfficeEquipment 2023-06-01 2024-05-31 10785555 d:OfficeEquipment 2024-05-31 10785555 d:OfficeEquipment 2023-05-31 10785555 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-06-01 2024-05-31 10785555 d:OwnedOrFreeholdAssets 2023-06-01 2024-05-31 10785555 d:CurrentFinancialInstruments 2024-05-31 10785555 d:CurrentFinancialInstruments 2023-05-31 10785555 d:CurrentFinancialInstruments d:WithinOneYear 2024-05-31 10785555 d:CurrentFinancialInstruments d:WithinOneYear 2023-05-31 10785555 d:ShareCapital 2024-05-31 10785555 d:ShareCapital 2023-05-31 10785555 d:RetainedEarningsAccumulatedLosses 2024-05-31 10785555 d:RetainedEarningsAccumulatedLosses 2023-05-31 10785555 c:FRS102 2023-06-01 2024-05-31 10785555 c:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 10785555 c:FullAccounts 2023-06-01 2024-05-31 10785555 c:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 10785555 2 2023-06-01 2024-05-31 10785555 e:PoundSterling 2023-06-01 2024-05-31 iso4217:GBP xbrli:pure

Registered number: 10785555










JP MEDICAL CONSULTANCY LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MAY 2024

 
JP MEDICAL CONSULTANCY LIMITED
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF JP MEDICAL CONSULTANCY LIMITED
FOR THE YEAR ENDED 31ST MAY 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of JP Medical Consultancy Limited for the year ended 31st May 2024 which comprise  the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the director of JP Medical Consultancy Limited in accordance with the terms of our engagement letter dated 22/06/2017Our work has been undertaken solely to prepare for your approval the financial statements of JP Medical Consultancy Limited and state those matters that we have agreed to state to the director of JP Medical Consultancy Limited in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than JP Medical Consultancy Limited and its director for our work or for this report. 

It is your duty to ensure that JP Medical Consultancy Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of JP Medical Consultancy Limited. You consider that JP Medical Consultancy Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of JP Medical Consultancy Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



MWS
 
Chartered Accountants
  
Kingsridge House
601 London Road
Westcliff-On-Sea
Essex
SS0 9PE
17 January 2025
Page 1

 
JP MEDICAL CONSULTANCY LIMITED
REGISTERED NUMBER: 10785555

BALANCE SHEET
AS AT 31 MAY 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
23,797
31,694

  
23,797
31,694

Current assets
  

Debtors: amounts falling due within one year
 5 
128,285
13,578

Cash at bank and in hand
 6 
305,562
484,997

  
433,847
498,575

Creditors: amounts falling due within one year
 7 
(8,004)
(89,434)

Net current assets
  
 
 
425,843
 
 
409,141

Total assets less current liabilities
  
449,640
440,835

Provisions for liabilities
  

Deferred tax
  
(5,949)
(650)

  
 
 
(5,949)
 
 
(650)

Net assets
  
443,691
440,185


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
443,591
440,085

  
443,691
440,185


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



J R Pelta
Page 2

 
JP MEDICAL CONSULTANCY LIMITED
REGISTERED NUMBER: 10785555

BALANCE SHEET (CONTINUED)
AS AT 31 MAY 2024

Director

Date: 17 January 2025

The notes on pages 4 to 8 form part of these financial statements.

Page 3

 
JP MEDICAL CONSULTANCY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MAY 2024

1.


General information

JP Medical Consultancy Limited is a private company limited by shares and incorporated in England. Its registered office is Kingsridge House, 601 London Road, Westcliff-on-Sea, Essex, SS0 9PE
Its principal place of business is Studio 4, London, SE1 2NZ

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
JP MEDICAL CONSULTANCY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MAY 2024

2.Accounting policies (continued)

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures and fittings
-
20%
Straight line
Office equipment
-
3 years straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 5

 
JP MEDICAL CONSULTANCY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MAY 2024

2.Accounting policies (continued)

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

2024
2023
£
£

Wages and salaries
12,000
12,000

Social security costs
400
421

Cost of defined contribution scheme
-
49,951

12,400
62,372


The average monthly number of employees, including directors, during the year was 1 (2023 - 1).

Page 6

 
JP MEDICAL CONSULTANCY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MAY 2024

4.


Tangible fixed assets





Fixtures and fittings
Office equipment
Total

£
£
£



Cost or valuation


At 1 June 2023
34,607
3,969
38,576



At 31st May 2024

34,607
3,969
38,576



Depreciation


At 1 June 2023
4,746
2,136
6,882


Charge for the year on owned assets
6,921
976
7,897



At 31st May 2024

11,667
3,112
14,779



Net book value



At 31st May 2024
22,940
857
23,797



At 31st May 2023
29,861
1,833
31,694


5.


Debtors

2024
2023
£
£


Trade debtors
126,271
13,455

Other debtors
22
2

Prepayments and accrued income
1,992
121

128,285
13,578



6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
305,562
484,997

305,562
484,997


Page 7

 
JP MEDICAL CONSULTANCY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MAY 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
4,700
24,416

Other taxation and social security
1,298
7,518

Other creditors
554
56,180

Accruals and deferred income
1,452
1,320

8,004
89,434



8.


Pension commitments

During the period the company paid employer pension contributions totalling £ nil (2023 : £ 49,951) into employees personal pension schemes. At the balance sheet date contributions payable totalled £Nil (2022: £Nil).


9.


Related party transactions

During the period the company paid employer pension contributions totalling £nil (2023: £49,951) into the directors personal pension scheme.
 


Page 8